Nonsurgical approaches to esophageal malignancy

Current Gastroenterology Reports

Volumn 5, Issue 3, 2003, Pages 213-220

  Sorbi, Darius ^a   Fleischer, David E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMATOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

ARGON PLASMA COAGULATION; ASPIRATION BIOPSY; BARRETT ESOPHAGUS; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DUODENOSCOPY; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; FLUORESCENCE ANALYSIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERMETHOD COMPARISON; MALNUTRITION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; POSITRON EMISSION TOMOGRAPHY; REVIEW; STENT; WEIGHT REDUCTION; ESOPHAGOSCOPY; ESOPHAGUS TUMOR;

ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS;

EID: 0037491473     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0022-x     Document Type: Review

References (49)

1. Kumbasar B: Carcinoma of esophagus: radiologic diagnosis and staging. Eur J Radiol 2002, 42:170-180.
2. Raijman I: Expandable metal stents for malignant esophageal obstruction. Tech Gastrointest Endosc 2001, 3:75-84.
3. Allum WH, Griffin SM, Watson A, Colin-Jones D: Guidelines for the management of oesophageal and gastric cancer. Gut 2002, 50:1-23.
4. Lambert R: Diagnosis of esophagogastric tumors. Endoscopy 2002, 34:129-138.
5. Romagnuolo J, Scott J, Hawes RH, et al.: Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc 2002, 55:648-654.
6. Kelly S, Harris KM, Berry E, Hutton J, et al.: A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001, 49:534-539.
7. Harewood GC, Wiersema MJ: A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer. Am J Gastroenterol 2002, 97:452-458.
8. Vazquez-Sequeiros E, Wiersema MJ: High-frequency US catheter-based staging of early esophageal tumors. Gastrointest Endosc 2002, 55:95-99.
9. Willis J, Cooper GS, Isenberg G, et al.: Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc 2002, 55:655-661.
10. Kato H, Kuwano H, Nakajima M, et al.: Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg 2002, 184:279-283.
11. Kato H, Kuwano H, Nakajima M, et al.: Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002, 94:921-928.
12. Zuccaro G, Gladkova N, Vargo J, et al.: Optical coherence tomography of the esophagus and proximal stomach in health and disease. Am J Gastroenterol 2001, 96:2633-2639.
13. Rajan E, J. BL, Gostout CJ: Endoscopic and histologic diagnosis of Barrett esophagus. Mayo Clinic Proc 2001, 76:217-225.
14. Kumagai Y, Inoue H, Nagai K, et al.: Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy 2002, 34:369-375.
15. Inui K: Endosonography and endoscopic magnetic resonance imaging. Best Pract Res Clin Gastroenterol 1999, 13:21-31.
16. Mayinger B, Horner P, Jordan M, et al.: Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancer. Gastrointest Endosc 2001, 54:195-201.
17. Mayinger B, Horner P, Jordan M, et al.: Endoscopic fluorescence spectroscopy in the upper GI tract for the detection of GI cancer: initial experience. Am J Gastroenterol 2001, 96:2616-2621.
18. Mayinger B, Neidhardt S, Reh H, et al.: Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. Gastrointest Endosc. 2001, 54:572-578.
19. Yoshida T, Inoue H, Kawano T, et al.: The ultrasonic tactile sensor: in vivo clinical application for evaluation of depth of invasion in esophageal squamous cell carcinomas. Endoscopy 1999, 31:442-446.
20. Inoue H, Fujimoto M, Fukami N, et al.: Endoscopic mucosal resection for esophageal cancer. Tech Gastrointest Endosc 2002, 4:23-27.
21. Inoue H, Fukami N, Yoshida T, Kudo SE: Endoscopic mucosal resection for esophageal and gastric cancers. J Gastroenterol Hepatol 2002, 17:382-388.
22. Soetikno RM, Inoue H, Chang KJ: Endoscopic mucosal resection: current concepts. Gastrointest Endosc Clin N Am 2000, 10:595-617.
23. Takeo Y, Yoshida T, Shigemitu T, et al.: Endoscopic mucosal resection for early esophageal cancer and esophageal dysplasia. Hepatogastroenterol 2001, 48:453-457.
24. Ponchon T: Endoscopic mucosal resection. J Clin Gastroenterol. 2001, 32:6-10.
25. Ahmad NA, Ginsberg GG: Safety and complications of endoscopic mucosal resection. Tech Gastrointest Endosc 2002, 4:10-14.
26. Narahara H, Iishi H, Tatsuta M, et al.: Effectiveness of endoscopic mucosal resection with submucosal saline injection technique for superficial squamous carcinomas of the esophagus. Gastrointest Endosc 2000, 52:730-734.
27. Adler DG, Baron TH: Endoscopic palliation of malignant dysphagia. Mayo Clin Proc 2001, 76:731-738.
28. Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001, 344:1681-1687.
29. Baron TH: A practical guide for choosing an expandable metal stent for GI malignancies: Is a stent by any other name still a stent? Gastrointest Endosc 2001, 54:269-272.
30. O'Donnell CA, Fullarton GM, Watt E, et al.: Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 2002, 89:985-992.
31. Aoki T, Takagi OY, Shinohara M, et al.: Comparative study of self-expandable metallic stents and bypass surgery for inoperable esophageal cancer. Dis Esophagus 2001, 14:208-211.
32. Abadal JM, Echenagusia A, Simo G, Camunez F: Treatment of malignant esophagorespiratory fistulas with covered stents. Abdom Imaging 2001, 26:565-569.
33. Decker P, Lippler J, Decker D, Hirner A: Use of Polyflex stent in the palliative therapy of esophageal carcinoma: results in 14 cases and review of the literature. Surg Endosc 2001, 15:1444-1447.
34. Geh JI: The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002, 38:300-313.
35. Polee MB, Eskens FA, van der Burg ME, et al.: Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. Br J Cancer 2002, 86:669-673.
36. Polee MB, Verweij J, Siersema PD, et al.: Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. Eur J Cancer 2002, 38:1495-1500.
37. Uno T, Kawakami H, Funami Y, et al.: Chemoradiation for patients with esophageal cancer aged 80 and older. Anticancer Res 2001, 21:4095-4097.
38. Stockeld D, Fagerberg J, Granstrom L, Backman L: Percutaneous endoscopic gastrostomy for nutrition in patients with oesophageal cancer. Eur J Surg. 2001, 167:839-844.
39. Akhtar K, Byrne JP, Bancewicz J, Attwood SE: Argon beam plasma coagulation in the management of cancers of the esophagus and stomach. Surg Endosc 2000, 14:1127-1130.
40. Yang H, Berner A, Mei Q, et al.: Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China. Acta Cytolo 2002, 46:445-452.
41. Maier A, Tomaselli F, Matzi V, et al.: Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma? Lasers Surg Med 2001, 29:323-327.
42. Javaid B, Watt P, Krasner N: Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study. Lasers Med Sci 2002, 17:51-56.
43. Weber J, Herman M, Kessel D, Fromm D: Current concepts in gastrointestinal photodynamic therapy. Ann Surg 1999, 230:12-29.
44. Alexander P, Mayoral W, Reilly HF III, et al.: Endoscopic Nd:YAG laser with aggressive multimodality therapy for locally advanced esophageal cancer. Gastrointest Endosc 2002, 55:674-679.
45. Wang Y, Zhou C, Jia J, et al.: YAG laser therapy combined with local chemotherapy of superficial carcinomas of the oesophagus and gastric cardia. Lasers Med Sci 2001, 16:299-303.
46. Gupta VK, Park JO, Jaskowiak NT et al.: Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol 2002, 9:500-504.
47. Lerut T, Coosemans W, De Leyn P, et al.: Optimizing treatment of carcinoma of the esophagus and gastroesophageal junction. Surg Oncol Clin North Am 2001, 10:863-884.
48. Inoue H: Treatment of esophageal and gastric tumors. Endoscopy. 2001, 33:119-125.
49. Fleischer D, Kessler F, Haye O: Endoscopic Nd:YAG laser therapy for carcinoma of the esophagus: a new palliative approach. Am J Surg 1982, 143:280-283.